Company profile for Prexton Therapeutics BV

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson’s disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Pivot Park - Building RK Kloosterstraat 9 5349 AB Oss
Telephone
Telephone
+41 22 552 22 92
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/lundbeck-adds-a-parkinsons-flop-to-its-list-of-setbacks-writing-off-a-1-1-billion-deal-on-mid-stage-failure/

John Carroll ENDPTS
31 Mar 2020

https://endpts.com/forbion-raises-270m-to-tap-the-potential-of-european-biotech-plays/

Amber Tong ENDPTS
11 Jul 2018
Lundbeck To Acquire Prexton Therapeutics
Lundbeck To Acquire Prexton Therapeutics

18 Mar 2018

// GLOBENEWSWIRE

https://globenewswire.com/news-release/2018/03/16/1441274/0/en/Lundbeck-to-acquire-Prexton-Therapeutics-adding-foliglurax-in-clinical-phase-II-to-its-pipeline-of-innovative-treatments-for-patients-suffering-from-Parkinson-s-disease.html

GLOBENEWSWIRE
18 Mar 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty